For those with type 2 diabetes , your healthcare team may recommend several strategies: Individualised medication plan : Specific guidance for each of your diabetes medications (metformin, sulfonylureas, SGLT2 inhibitors, insulin) following established UK protocols Enhanced blood glucose monitoring : More frequent self-monitoring to identify any changes in control Dietary consistency : Maintaining regular eating patterns where possible Clear targets : Typical perioperative blood glucose targets are 6-10 mmol/L (with an acceptable range of 4-12 mmol/L) [2] SGLT2 inhibitors (medications ending in '-flozin') are typically stopped 3 days before surgery to reduce the risk of diabetic ketoacidosis, according to UK guidance
Beyond its antioxidant activity, glutathione participates in detoxification, mitochondrial function, immune regulation, and cellular signaling, making it one of the most extensively studied molecules in biochemistry and regenerative research
The better question is which one is right for you, which you and your provider decide together and can adjust over time
Several clinical trials are being conducted for SUSTAIN's research project to examine its therapeutic impact on type 2 diabetic patients
Here are some conditions based on current literature and clinical practice where this stack may be beneficial: Slow healing from injury or surgery Chronic joint pain, tendinopathy, or musculoskeletal damage Gastrointestinal conditions such as leaky gut, IBD, or mucosal irritation Unexplained chronic inflammation Inflammatory autoimmune diseases Inflammatory skin conditions Generalized cell aging and tissue degeneration Systemic immune dysregulation It is to be noted that peptide therapy is not a foundation builder